bims-netuvoNerves in tumours of visceral organs
This report is maintained by Maksym V. Kopanitsa, Charles River Laboratories. It brings out roughly 8 papers per issue.
As of 2025‒10‒25 at 23:58:02 the report has nine subscribers.
0000‒00‒00
 Sign up
2025–10–26
2025–10–19
0000‒00‒00
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
2025–10–12
2025–10–05
2025–09–28
2025–09–21
2025–09–14
2025–09–07
2025–08–31
2025–08–24
2025–08–17
2025–08–10
2025–08–03
2025–07–27
2025–07–20
2025–07–13
2025–07–06
2025–06–29
2025–06–22
2025–06–15
2025–06–08
2025–06–01
2025–05–25
2025–05–18
2025–05–11
2025–05–04
2025–04–27
2025–04–20
2025–04–13
2025–04–06
2025–03–30
2025–03–23
2025–03–16
2025–03–09
2025–03–02
2025–02–23
2025–02–16
2025–02–09
2025–02–02
2025–01–26
2025–01–19
2025–01–12
2025–01–05
2024–12–29
2024–12–22
2024–12–15
2024–12–08
2024–12–01
2024–11–24
2024–11–17
2024–11–10
2024–11–03
2024–10–27
2024–10–20
2024–10–13
2024–10–06
2024–09–29
2024–09–22
2024–09–15
2024–09–08
2024–09–01
2024–08–25
2024–08–18
2024–08–11
2024–08–04
2024–07–28
2024–07–21
2024–07–14
2024–07–07
2024–06–30
2024–06–23
2024–06–16
2024–06–09
2024–06–02
2024–05–26
2024–05–19
2024–05–12
2024–05–05
2024–04–28
2024–04–21
2024–04–14
2024–04–07
2024–03–31
2024–03–24
2024–03–17
2024–03–10
2024–03–03
2024–02–25
2024–02–18
2024–02–11
2024–02–04
2024–01–28
2024–01–21
2024–01–14
2024–01–07
2023–12–31
2023–12–24
2023–12–17
2023–12–10
2023–12–03
2023–11–26
2023–11–19
2023–11–12
2023–11–05
2023–10–29
2023–10–22
2023–10–15
2023–10–08
2023–10–01
2023–09–24
2023–09–17
2023–09–10
2023–09–03
2023–08–27
2023–08–20
2023–08–13
2023–08–06
2023–07–30
2023–07–23
2023–07–16
2023–07–09
2023–07–02
2023–06–25
2023–06–18
2023–06–11
2023–06–04
2023–05–28
2023–05–21
2023–05–14
2023–05–07
2023–04–30
2023–04–23
2023–04–16
2023–04–09
2023–04–02
2023–03–26
2023–03–19
2023–03–12
2023–03–05
2023–02–26
2023–02–19
2023–02–12
2023–02–05
2023–01–29
2023–01–22
2023–01–15
2023–01–08
2023–01–01
2022–12–25
2022–12–18
2022–12–11
2022–12–04
2022–11–27
2022–11–20
2022–11–13
2022–11–06
2022–10–30
2022–10–23
2022–10–16
2022–10–09
2022–10–02
2022–09–25
2022–09–18
2022–09–11
2022–09–04
2022–08–28
2022–08–21
2022–08–14
2022–08–07
2022–07–31
2022–07–24
2022–07–17
2022–07–10
2022–07–03
2022–06–26
2022–06–19
2022–06–12
2022–06–05
2022–05–29
2022–05–22
2022–05–15
2022–05–08
2022–05–01
2022–04–24
2022–04–17
2022–04–10
2022–04–03
2022–03–27
2022–03–20
2022–03–13
2022–03–06
2022–02–27
2022–02–20
2022–02–13
2022–02–06
2022–01–30
2022–01–23
2022–01–16
2022–01–09
2022–01–02
2021–12–26
2021–12–19
2021–12–12
2021–12–05
2021–11–28
2021–11–21
2021–11–14
2021–11–07
2021–10–31
2021–10–24
2021–10–17
2021–10–10
2021–10–03
2021–09–26
2021–09–19
Maksym V. Kopanitsa also maintains a report bims-hummad on “Humanised mouse models of autoimmune disorders” .
Here are the seven most related reports.
 1. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-cagime“Cancer, aging and metabolism”, ∼ 36 p.p.i. ∼ 36 papers per issue
 2. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-medica“Metabolism and diet in cancer”, ∼ 24 p.p.i. ∼ 24 papers per issue
 3. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-meract“Metabolic reprogramming and anti-cancer therapy”, ∼ 16 p.p.i. ∼ 16 papers per issue
 4. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-meproc“Metabolism in Prostate Cancer”, ∼ 14 p.p.i. ∼ 14 papers per issue
 5. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-flamet“Cytokines and immunometabolism in metastasis”, ∼ 26 p.p.i. ∼ 26 papers per issue
 6. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-glucam“Glutamine cancer metabolism”, ∼ 14 p.p.i. ∼ 14 papers per issue
 7. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-instec“Intestinal stem cells and chemoresistance in colon cancer and intestinal regeneration”, ∼ 13 p.p.i. ∼ 13 papers per issue
This page is being maintained by Thomas Krichel. It was last updated on 2025‒10‒30 at 7:50.